AZN
Astrazeneca·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AZN fundamentals
Astrazeneca (AZN) released its earnings on Nov 6, 2025: revenue was 15.19B (YoY +11.94%), beat estimates; EPS was 2.38 (YoY +14.42%), beat estimates.
Revenue / YoY
15.19B
+11.94%
EPS / YoY
2.38
+14.42%
Report date
Nov 6, 2025
AZN Earnings Call Summary for Q3,2025
- Revenue Growth: 11% YoY driven by oncology (+16%), Biopharma (+8%), and Rare Disease (+6%).
- Pipeline Success: DESTINY-Breast05/02 trials demonstrate 53% survival benefit in early-stage breast cancer.
- Financial Strength: $12.2B free cash flow (9M), 15% EPS growth, and $80B 2030 target on track.
- Strategic Moves: U.S. government agreement, $5B+ baxdrostat potential, and 2026 $10B pipeline readouts.
EPS
Revenue
Revenue & Expenses
AZN has released its 2025 Q3 earnings report, with revenue of 15.19B, reflecting a YoY change of 11.99%, and net profit of 2.54B, showing a YoY change of 76.90%. The Sankey diagram below clearly presents AZN's revenue sources and cost distribution.
Key Indicators
Astrazeneca (AZN) key financial stats and ratios, covering profitability, financial health, and leverage.
Astrazeneca (AZN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Astrazeneca (AZN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Astrazeneca (AZN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Astrazeneca (AZN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Astrazeneca (AZN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Astrazeneca's revenue and profit?What is the revenue and EPS growth rate for Astrazeneca year over year?What is the market's earnings forecast for Astrazeneca next quarter?What does Astrazeneca do and what are its main business segments?What is Astrazeneca's gross profit margin?What were the key takeaways from Astrazeneca’s earnings call?What guidance did Astrazeneca's management provide for the next earnings period?Did Astrazeneca beat or miss consensus estimates last quarter?
